PT-141 (Bremelanotide) (10mg)
$45.00
PT-141 (Bremelanotide) (10mg) is offered by Biotech Peptides for laboratory and analytical research. Also called bremelanotide, this synthetic cyclic heptapeptide is a melanocortin receptor agonist studied in relation to MC1R, MC3R, and MC4R signaling.accessdata.fda+2
-
Product: PT-141 (Bremelanotide)
-
Alternative name: Bremelanotide
-
Listed quantity: 10 mg
-
Reference molecular formula: C₅₀H₆₈N₁₄O₁₀
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
PT-141 (Bremelanotide) (10mg) for Laboratory Research
PT-141 (Bremelanotide) (10mg) is offered by Biotech Peptides for laboratories investigating melanocortin receptor signaling, central nervous system pathways, and sexual-processing research. Bremelanotide is a synthetic cyclic heptapeptide and a non-selective agonist of melanocortin receptors.accessdata.fda+2
For laboratories looking to buy PT-141, this listing identifies a 10 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.
Explore our research peptides for sale to review other laboratory-use listings.
PT-141 Product Information
| Property | Listing information |
|---|---|
| Product name | PT-141 (Bremelanotide) |
| Alternative name | Bremelanotide |
| Listed quantity | 10 mg |
| Intended application | Laboratory and analytical research |
| Documentation inquiries | Include the product name and batch or lot number, where available |
The 10 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.
PT-141 Reference Molecular Characteristics
The following characteristics describe the PT-141 reference structure. They are not analytical confirmation of an individual commercial batch.
| Reference characteristic | Information |
|---|---|
| Peptide length | 7 residues |
| Reference sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Molecular formula | C₅₀H₆₈N₁₄O₁₀ |
| Approximate molecular weight | 1025.2 g/mol |
| CAS number | 189691-06-3 |
| Chemical class | Cyclic heptapeptide melanocortin agonist |
The sequence, molecular formula, molecular weight, and CAS number are documented in the PubChem Bremelanotide reference record and in the FDA Vyleesi label. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations.accessdata.fda+2
PT-141 and MC4R Research
Bremelanotide is a melanocortin receptor agonist that non-selectively activates several receptor subtypes with the following order of potency: MC1R, MC4R, MC3R, MC5R, MC2R. At therapeutic dose levels, binding to MC1R and MC4R is most relevant.accessdata.fda+1
A randomized, double-blinded, placebo-controlled, crossover clinical study evaluated the effects of MC4R agonism on sexual brain processing in 31 premenopausal women with hypoactive sexual desire disorder. The investigators reported that MC4R agonism significantly increased self-reported sexual desire for up to 24 hours post administration, compared with placebo.
Read the primary MC4R agonism study for the experimental design and limitations.
Cavernosal-Tissue Research
Research has explored the possible involvement of the nitric oxide-cyclic guanosine monophosphate pathway in the action of melanocortin agonists on erectile function. The investigators reported that disrupting pudendal nerves or inhibiting nitric oxide synthesis diminished melanocortin-agonist-induced increases in pressure within cavernosal tissues in anesthetized mouse models.accessdata.fda+1
These findings apply to a specific animal model and exposure protocol. They do not establish that a commercial PT-141 batch induces erections, improves sexual function, or produces a cosmetic effect in humans.accessdata.fda+1
Research Limitations
Published PT-141 research examines receptor signaling, cell-based assays, and limited clinical studies in premenopausal women with hypoactive sexual desire disorder. It does not establish that PT-141 treats erectile dysfunction, obesity, cell death, or any other condition.accessdata.fda+2
Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.
Documentation and Batch Verification
Before selecting PT-141 (Bremelanotide) (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:
-
Product name and batch or lot identifier.
-
Manufacturer specifications and chemical form.
-
Salt state and counterion information, where applicable.
-
Identity-testing methods and reported results.
-
Purity-testing methods and supporting analytical data.
-
Quantity or peptide-content measurements, where required.
-
Product-specific storage and handling instructions.
Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.
For inquiries, provide “PT-141 (Bremelanotide) (10mg),” the batch number where available, and the specific information your laboratory requires.
Storage and Handling
Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.
Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.
Frequently Asked Questions About PT-141 (Bremelanotide) (10mg)
What is PT-141?
PT-141 is bremelanotide, a synthetic cyclic heptapeptide and a non-selective agonist of melanocortin receptors.accessdata.fda+1
Is PT-141 the same as bremelanotide?
Yes. PT-141 and bremelanotide refer to the same molecule.pubchem.ncbi.nlm.nih+1
Does PT-141 activate MC4R?
Bremelanotide is a melanocortin receptor agonist that non-selectively activates several receptor subtypes, including MC4R. This does not establish that a commercial batch activates MC4R in humans.accessdata.fda+1
What does the 10mg designation mean?
It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.
Does published research verify this product?
No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.
Where can I find delivery information?
Review our shipping information for current order-processing and delivery terms.
Research Use Only
PT-141 (Bremelanotide) (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.
Review our Research-Use-Only Policy before ordering.
| Brand | Biotech Peptides |
|---|
Related products
ARA-290 (16mg)
ARA-290 (16mg) is offered by Biotech Peptides for laboratory and analytical research. Also called cibinetide, ARA-290 is a synthetic 11-residue peptide derived from the beta-helix domain of erythropoietin, studied in relation to innate repair receptor signaling and inflammatory pathways. 1181
-
Product: ARA-290
-
Alternative name: Cibinetide
-
Listed quantity: 16 mg
-
Reference molecular formula: C₅₁H₅₄N₁₆O₂₁
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
FOXO4-DRI (Proxofim) (10mg)
FOXO4-DRI (Proxofim) (10mg) is offered by Biotech Peptides for laboratory and analytical research. FOXO4-DRI is a synthetic D-retro-inverso peptide, also called Proxofim, studied in relation to FOXO4-p53 signaling and senescent-cell apoptosis. 1241
-
Product: FOXO4-DRI
-
Alternative name: Proxofim
-
Listed quantity: 10 mg
-
Reference molecular formula: C₂₂₈H₃₈₈N₈₆O₆₄
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
GHK Basic Tripeptide-1 (200mg) | Biotech Peptides
- Product: GHK Basic (Tripeptide-1)
- Listed quantity: 200mg
- Peptide sequence: Gly-His-Lys
- Molecular formula: C₁₄H₂₄N₆O₄
- Molecular weight: Approximately 340.38 g/mol
- CAS number: 49557-75-7
- Chemical form: Copper-free GHK reference structure
MGF (Mechano-Growth Factor) (5mg)
MGF (Mechano-Growth Factor) (5mg) is offered by Biotech Peptides for laboratory and analytical research. MGF is a synthetic 24-residue peptide derived from the E-domain of IGF-1Ec, studied in relation to muscle-cell proliferation, tissue-repair signaling, and cardiac ischemia models. 1065
-
Product: MGF
-
Full name: Mechano-Growth Factor
-
Listed quantity: 5 mg
-
Reference molecular formula: C₁₂₄H₂₀₄N₄₂O₄₁S
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Nonapeptide-1 (200mg)
- Product: Nonapeptide-1
- Alternative name: Melanostatine-5
- Listed quantity: 200mg
- Peptide length: 9 amino acids
- Reference sequence: Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH₂
- CAS number: 158563-45-2
Pentapeptide-18 (Leuphasyl) (200mg) | Biotech Peptides
Pentapeptide-18 (Leuphasyl) (200mg) is a synthetic pentapeptide listed for laboratory and analytical research involving peptide structure and cosmetic-science research models.
Pentapeptide-18 is also known as Leuphasyl and is structurally related to leucine-enkephalin, with a D-alanine residue at position two. Its research background includes investigations into neurotransmitter signaling and topical cosmetic formulations. Reference molecular information:- Listed quantity: 200mg
- Sequence: H-Tyr-D-Ala-Gly-Phe-Leu-OH
- Molecular formula: C₂₉H₃₉N₅O₇
- Molecular weight: Approximately 569.6 g/mol
- CAS number: 64963-01-5
- Alternative name: Leuphasyl
Sermorelin (5mg)
Sermorelin (5mg) is offered by Biotech Peptides for laboratory and analytical research. Sermorelin is a synthetic 29-residue GHRH analogue studied in relation to growth hormone secretion, receptor signaling, and neuroendocrine pathways. 1159
-
Product: Sermorelin
-
Full name: GHRH(1-29)-NH2
-
Listed quantity: 5 mg
-
Reference molecular formula: C₁₄₉H₂₄₆N₄₄O₄₂S
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
TB-500 (Thymosin Beta-4) (10mg)
TB-500 (Thymosin Beta-4) (10mg) is offered by Biotech Peptides for laboratory and analytical research. TB-500 is a synthetic 43-residue peptide derived from thymosin beta-4, studied in relation to cell migration, angiogenesis, and wound-repair signaling. 1153
-
Product: TB-500
-
Full name: Thymosin Beta-4
-
Listed quantity: 10 mg
-
Reference molecular formula: C₂₁₂H₃₅₀N₅₆O₇₈S
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
